FRANCHISE TRADE NOW OPEN AN ACCOUNT
Hot Pursuit
Prev Next
As on May 28, 2020 12:00 AM Your results on : Hot Pursuit    
Granules India gains as USFDA finds no NDMA impurities
28-May-2020 (11:10)
USFDA has tested samples from a few lots of the company's API (active pharmaceutical ingredient) and finished dosage tablets and it did not detect NDMA.

NDMA is classified as a probable human carcinogen (a substance that could cause cancer). It is a known environmental contaminant typically found in water and foods, including meats, dairy products and vegetables.

Granules India is a pharmaceutical manufacturing company. The company produces Finished Dosages (FDs), Pharmaceutical Formulation Intermediates (PFIs) and Active Pharmaceutical Ingredients (APIs). The company has a total of 27 ANDA approvals from US FDA (25 Final approvals and 2 tentative approvals).

On a consolidated basis, Granules India's net profit rose 6.2% to Rs 64.03 crore on 11.4% rise in net sales to Rs 703.96 crore in Q3 December 2019 over Q3 December 2018.

Volumes jump at Uflex Ltd counter
28-May-2020 (11:00)
Tube Investments spurts on decent Q4 numbers
28-May-2020 (10:48)
Avenue Supermarts snaps 3-day losing run
28-May-2020 (10:14)
Financials stocks rise
28-May-2020 (10:00)
Banking shares gain
28-May-2020 (10:00)
Capital Goods stocks edge higher
28-May-2020 (10:00)
Quess Corp declines on reporting Q4 net loss of Rs 630 cr
28-May-2020 (09:54)
Wipro Ltd Slips 1.61%, S&P BSE IT Sector index Shed 1.09%
28-May-2020 (09:45)
United Spirits slips after weak Q4 performance
28-May-2020 (09:33)
Aditya Birla Fashion slides after reporting Q4 net loss
28-May-2020 (09:31)
Finolex Cables Ltd Spikes 4.08%, S&P BSE Capital Goods index Rises 2.29%
28-May-2020 (09:30)
Adani Power gains as subsidiary signs PPA with MP Government
28-May-2020 (09:13)
Vedanta receives downgrade in credit rating
28-May-2020 (08:15)
Dabur India declines on weak Q4 performance
27-May-2020 (16:54)
Sun Pharma Q4 PAT declines 37% to 399 cr
27-May-2020 (16:03)
Coromandel International gains on stellar Q4 performance
27-May-2020 (15:29)
Max Financial Q4 PAT tumbles 97% to Rs 7 cr
27-May-2020 (15:08)
TVS Srichakra Ltd leads losers in 'A' group
27-May-2020 (15:00)
Krebs Biochemicals & Industries Ltd leads losers in 'B' group
27-May-2020 (14:45)
Connect with us :   
Globe
About us
Our Services
Milestones
Memberships
Core Values
Investor Relations
Product & Services
Broking
Institutional Broking
PMS
Clearing Services
Distribution
Research
Depository
Trade & Products
Globe Connect Pro
Globe Trade Smart
Globe Connect Mobile/Tablet
Globe News Connect
Globe e-KYC Application
NSDL e-KYC Signer Application
Mobile App Demo
Globe Referral Program
Globe Free Account Opening
Back Office
Back Office
CMS
CMS-TM
KYC/KDC Status
Mutual Fund
CAMS
RMS Policy
Helpdesk
Download Forms
Useful Links
BSE
NSE
SEBI
RBI
MCX
NCDEX
Exchange Holidays
Anti-Money Laundering Policy
Policies, Procedures, Rights, Obligations and RDD
Additional Policy and Procedures
Scores

Funds Payout Policy

Shortages Obligation Arising Out Of Internal Netting of Trades

Policies of Globe Commodities Limited
Guidance Note on FATCA and CRS May 2016
Right and Obligation, RDD, Guidance Note in Vernacular Language - Equity | Commodity
Additional Risk Disclosure for Trading into Commodity options
In case of any grievances pleae write to
Investor_trading@globecapital.com /  igr@globecapital.com (For Trading)     globedp@globecapital.com (For DP)    Investor_pms@globecapital.com (For PMS)     
commigr@globecapital.com (For Commodities)
Equity SEBI Registration No INZ000177137, Exchange Registration Nos : NSE TM Code - 06637, Clearing No.- M50302|BSE Clearing No: 3179|MSEI TM Code - 1004 ,Clearing No.- 4| MCX TM No: 8091,Clearing No: 8090 | NCDEX TM No:1287, Clearing No: -M51085|ICEX TM ID-2084 | SEBI Registration for DP : IN-DP-NSDL-97-99, NSDL- DP ID: IN300966, CDSL DP ID: 12020600 | SEBI Research Analysts Registration No :INH100001187 | SEBI PMS Registration No:INP000002361 CMBPID NCL CM :- IN555502
* Through subsidiary Globe Commodities Ltd. --> Commodity SEBI Regn. No. - INZ000024939, Exchange Regn. Nos. - MCX CM ID: 8550 TM ID: 10735, NCDEX CM ID: M50011 TM ID: 00012, NMCE ID: CL0111, ICEX ID: 1009, NCDXSPOT-CR-07-10011,
** Through step in subsidiary Globe Comex International DMCC --> DGCX **TM Id.1064, CM Id.3064*
"We also do Pro-Account trading in Commodity Segment.."
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
Attention Investors:
"Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your Stock Brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors"
"Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL/CDSL on the same day......................issued in the interest of investors."
"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
© 2013 Globe Capital Market Limited. All rights reserved
Designed, Developed and Content powered by CMOTS Infotech (ISO 9001:2015 Certified) Privacy Policy Disclaimer Terms and Conditions